Results 131 to 140 of about 48,625 (267)
Current Pharmacological Approaches to Prevent and Treat Post-Menopausal Osteoporosis
Osteoporosis characterized by low bone mass and structural deterioration of bone tissue; has a huge impact on public health through high morbidity, mortality and economic costs associated with resultant fractures.
YANG, RONG-SEN;LIU, SHING-HWA +1 more
core +1 more source
Estimation of level of knowledge in young adult women about the postmenopausal osteoporosis
Background: Postmenopausal osteoporosis and its complications cause significant morbidity and mortality, in elderly women. Having knowledge about bone health in young adult women is crucial to gain good bone strength and maintain it at an optimal level ...
Devarakonda Obulapathi +2 more
doaj +1 more source
Abstract This study evaluates in non‐trained healthy women the influence of oestradiol (E2) on exercise induced muscular damage (EIMD) and performance. Thirty‐six young healthy women performed a step‐exercise until exhaustion, assessing the number of repetitions, pain perception and well‐being (questionnaires, 15 min and at 48 h post‐exercise), blood ...
David Ramiro‐Cortijo +6 more
wiley +1 more source
Aging‐associated upregulation of NPY1R drives p‐CREB activation, triggering inflammation, mitochondrial dysfunction, and extracellular matrix imbalance to promote ovarian senescence. Pharmacological inhibition of NPY1R with BIBO 3304 restores ovarian homeostasis, highlighting a therapeutic strategy for reproductive aging. ABSTRACT Ovarian senescence is
Junnan Fang +15 more
wiley +1 more source
ObjectivesTo compare and assess the performance of 6 osteoporosis risk assessment tools for screening osteoporosis in Malaysian postmenopausal women.MethodsSix osteoporosis risk assessments tools (the Simple Calculated Osteoporosis Risk Estimation [SCORE]
Wong, Kok Thong +9 more
core +2 more sources
Objective We evaluated the role of 25‐hydroxyvitamin D (25[OH]D), prednisone, and other risk factors for bone mineral density (BMD) loss and osteoporosis in systemic lupus erythematosus (SLE). Methods We calculated the association between 25(OH)D levels and other potential risk factors and BMD measures (spine T scores) and osteoporosis (defined as a T ...
Nima Madanchi +4 more
wiley +1 more source
PhDThe role of aromatase inhibitors (AIs) in breast cancer has expanded since their introduction in the mid-1990s. They are superior to tamoxifen in the treatment of postmenopausal women with oestrogen dependant tumours in the metastatic, neoadjuvant ...
Singh, Shalini
core
ABSTRACT Objectives The relationship between tooth loss and glycemic control status in diabetes is inconclusive. Material and Methods Using data from the 2014–2018 Korean National Health and Nutrition Examination Survey (KNHANES), 2146 adults with diabetes aged ≥ 40 years were categorized by number of remaining teeth (0–19, 20–27, and ≥ 28 ...
Eun Sik Lee +9 more
wiley +1 more source
The aim of this study was to compare the effect of alendronate and calcitonin treatments on bone mineral density (BMD) and quality of life of women with postmenopausal osteoporosis.
İ. Dalkıran +4 more
core
Food and Medicine Homologous Plants in Osteoporosis: A Scoping Review of Preclinical Evidence
Food and medicine homologous (FMH) plants and their bioactive compounds exhibit potential osteoprotective effects through multiple complementary mechanisms, including estrogen‐like signaling, attenuation of oxidative stress, modulation of the gut microbiota–bone axis, and regulation of autophagy.
Long Zhao +4 more
wiley +1 more source

